Breast surgery is a traumatic experience for a woman, no matter whether breast-conservation surgery (BCS) or a mastectomy. Trauma levels are greatly enhanced, if pathological evaluation findings of an excised breast tumour following a lumpectomy suggest that additional cancer may still be in the margins, and a second surgical procedure is required. A new system with the ability to accurately…
Academic labs and biotech firms pioneer multi-cancer early detection with emerging technologies. Screening for multiple cancers with a simple blood or urinary draw could be a game-changer. Two research teams in particular have advanced the field.
A low-cost technology involving nano-sized antimicrobial compounds against tuberculosis has been developed by researchers at São Paulo State University (UNESP).
A team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s Diseases. The biosensor can also transmit the results wirelessly.
Faster, more accurate and cost-effective testing: Experts outline the beginnings and evolution of “lab-on-a-chip” technology, and its benefits for advanced and next-gen operational platforms.
A team of researchers and scientists from the University of California, San Diego (UCSD) have developed a stick-on ultrasound patch, the first fully integrated wearable system for evaluating cardiovascular function while people walk, run, or even ride a bicycle. This Ultrasonic system-on-patch (USoP) is the result of several years of research conducted by nanoengineering department engineers.
Brain tumour progression to a malignant state is believed to be the result of an intricate interplay between cancer cells and the tumour microenvironment. Greek researchers shed new light on the mechanisms.
Post-pandemic problems, ageing societies, the impact of climate change on human health: To find solutions for new and ongoing healthcare challenges, thinking outside the box is crucial. This year’s Medical Taiwan Health & Care Expo took this approach to heart: True to its motto “beyond healthcare”, the event showcased a wide range of innovative products, promising start-up presentations…
The "Future Pavilion", an immersive experience that showcases the latest in smart medical and digital health products and services, will be presented at Medical Taiwan (June 8-10).
Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.
Researchers at the Universitat Autònoma de Barcelona (UAB) have developed a new type of nanoparticles inspired by the structure of amyloids, capable of neutralising the SARS-CoV-2 virus.
Scientists are developing a new kind of light-activated cancer treatments. This would work by switching on LED lights embedded close to a tumour, which would then activate biotherapeutic drugs.
Combining single-cell data with a self-learning algorithm reveals how structural changes in chromosomes can trigger cancer. This could pave the way for personalized cancer treatments.
Scientists from Singapore discovered a novel low-cost method of testing for cancers. The test sequences heated clinical samples to isolate cancer-specific signatures found in a patient’s blood.
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
Researchers at Nottingham Trent University and Nottingham University Hospitals NHS Trust have developed a new biosensor capable of accurately monitoring the condition of a chronic wound.
Two-dimensional (2D) cultured cell lines and animal models have been the principal research tools for the past decade, but have several shortcomings. Three-dimensional cell cultures, or organoids, show great promise here.
Researchers have shown that aggregation of amyloid-beta, one of two key proteins implicated in Alzheimer’s disease, causes cells to overheat and ‘fry like eggs.’
Over the last 50 years, malaria parasites have developed resistance to seven drugs, but a new way to identify future antimalarials holds promise.
With micro-organisms and viruses constantly developing, mutating, and evolving, diagnostics must adapt just as rapidly. Advanced laboratory technology and instruments are undeniably a prerequisite for best practice in life sciences and biotechnology.
Dr Jan Stallkamp, Professor for Automation in Healthcare and Biotechnology, has a vision: robots that can treat patients more efficiently and more precisely than any human physician.
Ion-mobility spectrometry (IMS) offers opportunities for rapid diagnosis and clinical decision-making due to breath analysis. As a rapid separation tool, it has clinical value in the identification and analysis of proteins, peptides, lipids, and glycans. The tool is already used as an exhaled drug monitor for anaesthetised patients. It is flexible, portable and has use for point-of-care testing,…
AI-designed Xenobots reveal an entirely new form of biological self-replication—promising for regenerative medicine.
Video streaming of surgeries, augmented reality displays and at-home assessment of sleep apnea: Medtech companies from Taiwan will showcase their newest products at Medica in Düsseldorf. Ahead of the trade fair, the Taiwan External Trade Development Council (TAITRA) presented award-winning examples of the nation’s ingenuity.
A new mechanism that stops the progression of Huntington’s disease in cells has been identified by scientists at the University of Cambridge and University College London (UCL), as part of their research groups at the UK Dementia Research Institute. Researchers say the breakthrough study, published in Cell Reports, could lead to much needed therapies for the rare genetic disease, which is…
A new paper co-written by a University of Illinois Urbana-Champaign scholar who studies the legal and ethical implications of advanced biotechnologies outlines an unexplored tool to regulate the medically and ethically dubious practice of heritable human-genome editing: patent law.
Researchers identify two sugar-binding proteins that impede the viral entry of circulating SARS-CoV-2 variants. The team, spearheaded by researchers at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – may have found the “Achilles’ heel” of the virus, with potential for pan-variant therapeutic interventions. The findings are now published in the EMBO…
To date, there are no effective antidotes against most virus infections. An interdisciplinary research team at the Technical University of Munich (TUM) has now developed a new approach: they engulf and neutralize viruses with nano-capsules tailored from genetic material using the DNA origami method. The strategy has already been tested against hepatitis and adeno-associated viruses in cell…
A new way to target a mutant protein which can cause the deadliest of cancers in humans has been uncovered by scientists at Leeds. The mutated form of the RAS protein has been referred to as the “Death Star” because of its ability to resist treatments and is found in 96% of pancreatic cancers and 54% of colorectal cancers. RAS is a protein important for health but in its mutated form it can…
Excessive noise, hearing loss, vascular constriction, old age – hearing difficulties can be caused by many factors. To help improve the quality of life of people with hearing impairment, Mannheim start-up Vibrosonic have developed a new hearing aid with an integrated loudspeaker that sits directly on the eardrum. This hearing contact lens is not an implant, and the sound quality it delivers…
Researchers at Northwestern and George Washington (GW) universities have developed the first-ever transient pacemaker — a wireless, battery-free, fully implantable pacing device that disappears after it’s no longer needed. The thin, flexible, lightweight device could be used in patients who need temporary pacing after cardiac surgery or while waiting for a permanent pacemaker. All components…
With new Medical Device Regulations (MDR) now in force across Europe, the UK has chosen to retain pre-existing rules while also introducing mechanisms to allow it to draw up separate rulings for the sector in the future. The MDR took effect on May 26, aiming to harmonise and strengthen the pre-existing regulatory regime for medical devices, and enhance protection for consumers.
Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic tool that could screen for cardiovascular disease while a patient is already being screened for cancer has the potential to expedite a diagnosis, accelerate treatment, and…
Self-organizing heart organoids – developed at the Austrian Academy of Sciences – are also effective injury- and in vitro congenital disease models. These “cardioids” may revolutionize research into cardiovascular disorders and malformations of the heart. The results are published in the journal Cell.
Researchers from Tel Aviv University have created an artificial intelligence platform that can identify the specific proteins that allow bacteria to infect the intestines.
Researchers from Charité – Universitätsmedizin Berlin and the Francis Crick Institute have developed a mass spectrometry-based technique capable of measuring samples containing thousands of proteins within just a few minutes. It is faster and cheaper than a conventional blood count. To demonstrate the technique’s potential, the researchers used blood plasma collected from Covid-19 patients.…
Using a nanopore, researchers have demonstrated the potential to reduce the time required for sequencing a glycosaminoglycan — a class of long chain-linked sugar molecules as important to our biology as DNA — from years to minutes. Research to be published this week in the Proceedings of the National Academies of Sciences shows that machine-learning and image recognition software could be…
Researchers at ZHAW Zurich University of Applied Sciences are working with the Swiss company Osmotex AG to develop a self-disinfecting mask that inactivates viruses at the push of a button. The prototype of this mask made of electrochemical textiles shows an antiviral effect of over 99 percent. Further applications such as sterilizable seat covers are being examined.
Olympus Corporation announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities. Quest offers advanced fluorescence imaging systems (FIS) for the medical field, enabling more surgical endoscopy capabilities, compared to conventional imaging technologies.
A new type of ultra-efficient, nano-thin material could advance self-powered electronics, wearable technologies and even deliver pacemakers powered by heart beats.
Disruption of gut bacteria by antibiotics soon after birth can affect the maturation of the immune system, say researchers at Rutgers University-New Brunswick. Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to their research. The study, published in Genome Medicine, provides further evidence…
Researchers have designed a fluid that works like a luminous ink to obtain very sharp images of damaged tissues, organs and cartilages in diagnostic tests. This new compound, still in the laboratory phase, reduces adverse effects on the human body because it allows lower amounts to be injected and the dose to be targeted only at the affected area.
Researchers have developed a human cell ‘membrane on a chip’ that allows continuous monitoring of how drugs and infectious agents interact with our cells, and may soon be used to test potential drug candidates for COVID-19. The researchers, from the University of Cambridge, Cornell University and Stanford University, say their device could mimic any cell type - bacterial, human or even the…
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge. The team's latest in-vitro results, published in Biomaterials Science, suggest that the…
Infection with the novel coronavirus SARS-CoV-2 follows a highly variable course: some of those infected do not even notice it, while others become so seriously ill that their lives are placed at risk. Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin and their colleagues from Leipzig and Heidelberg have now discovered that the immune system has a…
Toshiba Corporation and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, have together developed a “tumor-tropic liposome technology” for gene therapy. The technology uses unique, nano-sized biodegradable liposomes developed by Toshiba to accurately and efficiently deliver therapeutic genes to targeted cancer cells, and achieves safer gene delivery…
Roswell Biotechnologies, Inc., a manufacturer of molecular electronics sensor chips, and imec, a research and innovation hub in nanoelectronics and digital technologies, announced a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains behind Roswell Technologies' new platform for DNA sequencing, to support precision medicine,…
As coronavirus disease COVID-19 continues to jet and alight invisibly around the globe, scientists now report that the virus has mutated to become two strains: the older ‘S-type’ appears milder and less infectious, while the later-emerging ‘L-type’, is more aggressive, spreads more quickly, and currently accounts for about 70 per cent of cases. Worldwide, medical researchers are exploring…
Biotechnology company bioMérieux, a world leader in the field of in vitro diagnostics, is announcing the forthcoming launch of 3 different tests to address the COVID-19 epidemic and to meet the different needs of physicians and health authorities in the fight against this emerging infectious disease. bioMérieux has finalized the development of the SARS-CoV-2 R-Gene test. This real-time PCR test…
A University of British Columbia (UBC) researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in China. Dr. Josef Penninger, director of UBC’s Life Sciences Institute and Canada 150 Chair in Functional Genetics, is working closely with Vienna-based Apeiron Biologics…
Scientists at the University of Bologna have conducted the largest analysis of coronavirus 2019-nCoV genomes sequenced so far. This analysis confirms that the virus originates in bats and shows a low variability: the virus heterogeneity is low. At the same time, researchers identified a hyper-variable genomic hotspot in the proteins of the virus responsible for the existence of two virus…
Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keeps them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation, saving many lives of patients with severe liver diseases or cancer. Until now, livers could be stored…
A popular proverb in Mandarin goes ‘Hearing something a hundred times is not as good as seeing it once’ (百聞不如一見). Visiting the Taiwan pavilion at this year’s Medica, it’s clear to see that the Bureau of Foreign Trade (MOEA) from Taiwan, together with the Taiwan External Trade Development Council (TAITRA) and its foster companies, have taken this sentiment to heart.
Contrary to common belief, blue light may not be as disruptive to our sleep patterns as originally thought – according to University of Manchester scientists. According to the team, using dim, cooler, lights in the evening and bright warmer lights in the day may be more beneficial to our health. Twilight is both dimmer and bluer than daylight, they say, and the body clock uses both of those…
Next generation sequencing, big data, microeconomics and more: At the Future of Personalized Medicine (FOPM) Summit for Oncology in Munich, experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics came together to discuss the Future of Medicine. Group Futurista, the organizers of the 2-day networking event, are happy to announce that the summit was a huge success. Their…
Health tech Made in Taiwan is among the mainstays of every MEDICA; this year’s fair is no exception. In co-operation with the Bureau of Foreign Trade (BOFT) of the Taiwanese Ministry of Economics and the Taiwan External Trade Development Council (TAITRA), 20 world-class healthcare companies are demonstrating innovative medical solutions based on national advances in Artificial Intelligence…
From an initial focus on innovative manufacturing, in-house ICT technologies drove production efficiency and quality. Today, Taiwan has advanced to become a leader with its "Asian Silicon Valley" concept. The government also wants to further strengthen Taiwan's key position by independently developing medical products that meet the high demands of international markets – at…
Researchers at Rensselaer Polytechnic Institute have developed a way to 3D print living skin, complete with blood vessels. The advancement, published in Tissue Engineering Part A, is a significant step toward creating grafts that are more like the skin our bodies produce naturally. “Right now, whatever is available as a clinical product is more like a fancy Band-Aid,” said Pankaj Karande, an…
With KardioKompassi, researchers from the University of Helsinki have developed an interactive web tool that aims to predict and prevent cardiovascular disease. The application for patients and doctors uses traditional health information combined with genome information, including 49,000 DNA variations associated with the disease. Using this data, the risk calculator evaluates the risk of cardiac…
For decades now, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing processes and systems for cleaning, sterilization, and surface modification. The newly in-house developed process, called SULEEI, makes it possible to sterilize (S) and preserve decellularized pericardial tissue by means of photo-initiated ultraviolet (U) crosslinking…
New simulation technology developed by TU Graz is designed to make the production of biopharmaceuticals more efficient, cost-effective and comprehensible for manufacturers.
When it comes to genetics, Estonia is considered a trailblazer, as the ambitious Estonian Genome Project (Eesti Geenivaramu) shows. Its objective is to test the genome of every citizen for the risk of diseases. Dr Jaanus Pikani talks about the initial difficulties which the genome project encountered and about its potential for Estonian – and possibly worldwide – healthcare.
Researchers at ETH Zurich have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously. The biotechnological method CRISPR-Cas offers a relatively quick and easy way to manipulate single genes in cells, meaning they can be precisely deleted, replaced or modified. Furthermore, in recent years,…
A team led by scientists at the U.S. Department of Energy (DOE) Joint Genome Institute (JGI) developed an algorithm that a computer could use to conduct a similar type of search in microbial and metagenomic databases. In this case, the machine “learned” to identify a certain type of bacterial viruses or phages called inoviruses, which are filamentous viruses with small, single-stranded DNA…
Bacteria have fascinating properties. They adapt excellently to their respective environment, and they existed long before humans. Their toughness has led to the fact that bacteria have successfully spread all over the world for three billion years – even in places where humans could not survive, for example in the hottest springs and in the coldest places on earth. However, they were only…
The future of medicine is biological – and scientists hope we will soon be using 3D-printed biologically functional tissue to replace irreparably damaged tissue in the body. A team of researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has been working with the University of Stuttgart for a number of years on a project to develop and optimize suitable…
Biotechnologists, physicists, and medical researchers at FAU have developed technology for microscopic imaging in living organisms. A miniaturised multi-photon microscope, which could be used in an endoscope in future, excites the body’s own molecules to illuminate and enables cells and tissue structures to be imaged without the use of synthetic contrast agents. The findings have now been…
In a major medical breakthrough, Tel Aviv University researchers have "printed" the world's first 3D vascularised engineered heart using a patient's own cells and biological materials. Until now, scientists in regenerative medicine — a field positioned at the crossroads of biology and technology — have been successful in printing only simple tissues without blood vessels. "This…
When the first antibiotics were discovered in the early 20th century, the rate of death from infectious diseases fell dramatically. But the emergence of multidrug-resistant bacteria as a result of antibiotic misuse is raising fears that by 2050, these same diseases will once again become the leading cause of death worldwide. In a bid to boost the arsenal available to tackle this threat,…
A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing. The Cancer Research UK and Wellcome Trust funded study, published in the journal Cancer Cell, showed that the drugs, called PARG inhibitors, can kill ovarian cancer cells by targeting weaknesses within their ability to copy their DNA. The first-in-class…
Jhy-Wey Shieh sees the link between Taiwan and Germany as obvious: ‘The word “trade” – of central importance for Medica – starts with “t” for Taiwan and contains “de” for Germany – there is no better way to put it.’ Even though the Taiwanese ambassador’s linguistic journey was not to be taken too seriously, this year’s presentation from the Taiwan External Trade…
The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Nature of favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific characteristics of patients’ individual tumors and immune systems. For the first time, the feasibility of such a highly personalized form of…
Successful pilot scheme means TERR-eSanté will be rolled out for the whole of the Ile-de-France. The French have a reputation as early adopters of telemedicine driven by the desire to modernise healthcare by the judicious use of the latest technology. The first ‘carte vitale’ (national health card) with a microchip was introduced in 1998. Since 2011, the information stored on the cards has…
Taiwan’s long-term investment in research and development has transformed the country from the low-cost production center of yesterday into the go-to source for original technologies for the global community of healthcare professionals and medical device manufacturers. Still, Taiwan develops and manufactures high-quality medical devices at costs that are far lower than those in Europe and the…
It is non-invasive, delivers a chance of early diagnosis, prognostic information and sequential monitoring, and, believes Professor Francesco Salvatore, the enormous potential of liquid biopsies has still to be reached. However, the positive results obtained so far have ‘opened the door to a promising new multi-faceted group of tumour markers, at present collectively designated “liquid…
The complex structure of breast tumours makes treatment a medical challenge. A promising, novel selenium-based breast cancer nanoparticle therapy by the Austrian Centre of Industrial Biotechnology (acib) together with other partners in the EU-project Neosetac could change that: It has proved to boost the active agent delivery and assure it's active only in the target tissue while also bringing…
While the role of the laboratory in disease diagnosis and management has expanded in recent years, causing an overwhelming rise in testing demands, the availability of skilled technologists and specialists has been diminishing. To meet the needs of an overworked and increasingly generalized workforce, today’s products not only must deliver more clinical data than ever before, but also must be…
Physicians have been performing surgery with the assistance of x-ray technology for almost half a century. While this technology has been progressing steadily, its limitations continue to be a major challenge. Thus, many professionals agree: it's time for our method to be changed. Taiwan Main Orthopaedics Biotechnology introduced the worldwide first smart surgical glasses.
For the first time, researchers at University of California San Diego School of Medicine and Imperial College London, with international collaborators, have determined that Kawasaki disease (KD) can be accurately diagnosed on the basis of the pattern of host gene expression in whole blood. The finding could lead to a diagnostic blood test to distinguish KD from other infectious and inflammatory…
Austrian researchers have accomplished an astounding feat: They created organoids that mimic the onset of brain cancer. This method not only sheds light on the complex biology of human brain tumors but could also pave the way for new medical applications.
Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics. The antibiotic, first identified by Nosopharm, is unique and promising on two fronts: its unconventional source and its distinct way of killing bacteria, both of which suggest the compound…
Throughout life, DNA is constantly being damaged by environmental and intrinsic factors and must be promptly repaired to prevent mutations, genomic instability, and cancer. Different types of damages are repaired by numerous proteins organized into damage-specific pathways. The proteins from different pathways must be spatially and temporally coordinated in order to efficiently repair complex DNA…
3-D visualisation, augmented reality, automated tumour classification – today, the Republic of China produces cutting-edge medical technology and it’s a long time since ‘Made in Taiwan’ stood for inferior, copied products. Over recent years, this island state has successfully morphed into a productive and, above all, innovative manufacturer of medical technology available on the world…
In a spectacular development, Spanish researchers demonstrate for the first time that 3-D printing can be used to produce human skin deemed appropriate for transplants and testing applications.
BBI Solutions (BBI), immunoassay developer and reagent supplier, acquired Maine Biotechnology Services Inc. (MBS) in July 2017, adding antibody development to the firm’s end to end assay development services. This also strengthens BBI’s reagents antibodies portfolio, providing a wide range of high quality biomarkers for infectious disease.
The Russian biotechnology company Biocad plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of Biocad. The biosimilar products could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis.
Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Researchers exploring combination therapies have recently discovered improved survival rates by up to one year when patients treated with a newly formulated chemotherapy regimen are also given radiation therapy.
Celebrating 40 years of PCI, cardiologists fret over their future with big data, machine learning and robots.
Medical Fair Thailand 2017 will be its largest edition yet, with booth space fully sold out since May, featuring 700 exhibitors from 45 countries including 18 National Pavilions and country groups on a show floor that has expanded by 20% compared to 2015, at the Queen Sirikit National Convention Center. Held biennially, Medical Fair Thailand 2017 confirms its position as Thailand’s most…
There hasn't been a gold standard for how orthopedic spine surgeons promote new bone growth in patients, but now Northwestern University scientists have designed a bioactive nanomaterial that is so good at stimulating bone regeneration it could become the method surgeons prefer.
Over the next few years, in a research project funded by the EU, an international consortium is developing a new technology for a better treatment of multiple sclerosis. The idea of the innovative “Nose2Brain” approach is to transport a special active substance directly through the nose into the central nervous system.
MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart failure repair. The production methods are based on the scientific work from the group of Prof. Dr.…
An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the Autism spectrum of disorder (ASD), based upon a recent study. The algorithm, developed by researchers at Rensselaer Polytechnic Institute, is the first physiological test for autism and opens the door to earlier diagnosis and potential future development of therapeutics.
Project will explore quantitative MRI metrics for more informed treatment decision making
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
ETH Researchers have used the simplest approach yet to produce artificial beta cells from human kidney cells. Like their natural model, the artificial cells act as both sugar sensors and insulin producers.
When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she’s describing a Tom Clancy military espionage novel.
At the MEDICA 2016 IMMS is presenting its first approaches for the personalized diagnostics of cancer using a prototype device. It was developed in the three-year research project INSPECT which started in June 2016.
To treat or not to treat? That is the question researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing.
As men appear to have higher risk of cardiovascular disease (CVD) than women of a similar age – with vascular calcification a strong predictor of mortality and morbidity from CVD – a team from the University of Edinburgh hopes that exploration of a link between gender and calcification could help unlock the pathway to new therapies. The researchers have been looking at whether sex hormones…
They may be slimy, but they are a perfect environment for microorganisms: biofilms. Protected against external influences, here bacteria can grow undisturbed, and trigger diseases. Scientists at Kiel University, in cooperation with colleagues at the Hamburg University of Technology (TUHH) in Hamburg-Harburg, are researching how it can be possible to prevent the formation of biofilms from the…
Scientists at the Institute of Molecular Biotechnology (IMBA) and the Max F. Perutz Laboratories (MFPL) in Vienna have discovered a new way to turn the immune system’s weapons against fungal invaders. This knowledge could lead to the development of new and improved anti-fungal treatments.
Most people recoil at the thought of ingesting E. coli. But what if the headline-grabbing bacteria could be used to fight disease? Researchers experimenting with harmless strains of E. coli — yes, the majority of E. coli are safe and important to healthy human digestion — are working toward that goal. They have developed an E. coli-based transport capsule designed to help next-generation…
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the American Society for Microbiology (ASM) are jointly organizing a conference in Vienna from 21 – 23 September 2016 to help researchers accelerate the development of new antimicrobials for drug-resistant infections.
An international team led by researchers at the Austrian Institute of Molecular Biotechnology (IMBA) in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. An already approved drug could be quickly available and would then be the first breast cancer prevention drug.
The Syndicat des Biologistes (SDB) and the Syndicat National des Biologistes des Hôpitaux (SNBH) are refounding the leading event in Medical Biology: the 60th edition of JIB and the 45th Colloque National des Biologistes will be held this year in Paris Expo Porte de Versailles, Hall 4.
In patients suffering from Type 1 diabetes, the immune system attacks the pancreas, eventually leaving patients without the ability to naturally control blood sugar. These patients must carefully monitor the amount of sugar in their blood, measuring it several times a day and then injecting themselves with insulin to keep their blood sugar levels within a healthy range. However, precise control…
Su-Chun Zhang, a pioneer in developing neurons from stem cells at the University of Wisconsin-Madison, has created a specialized nerve cell that makes serotonin, a signaling chemical with a broad role in the brain.
When it comes to fending off disease and helping prevent people from falling ill, the body’s immune system – armed with T-cells that help eliminate cancer cells, virus-infected cells and more – is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been…
Founded in 1968, The Sysmex Corporation has challenged its way past far larger companies to become one of the leading healthcare companies around the world. How? By focusing constantly on one objective: maximising the strength of our people, knowledge and resourcefulness to live up to our mission statement: Shaping the Advancement of Healthcare.
Life sciences company Proteomics International Laboratories (ASX: PIQ) is pleased to announce that it has produced and validated a predictive test for the diagnosis of diabetic kidney disease (DKD). The test, called PromarkerD, is the world's first proteomics-derived predictive (prognostic) test for the diagnosis of DKD, and represents a global breakthrough in the diagnosis and treatment of the…
21-25 June 2015 - Palais des Congrès of Paris, France Exceptionally this year, the 21st IFCC EFLM Congress with of the 60th Journées Internationales de Biologie (JIB) will be held together to form a very special event.
The EU-funded MycoSynVac project combines gene engineering and biotechnology to design a novel veterinary vaccine chassis based on the bacterium Mycoplasma pneumoniae.
Researchers from the Universitat Autònoma de Barcelona (UAB) and the UAB Institute of Biotechnology and Biomedicine discovered that the signalling route triggered by the ATM protein regulates DNA repair during the production of spermatocytes by meiosis, the cell division process which yields spermatozoa.
Regenerative medicine uses cells harvested from the patient’s own body to heal damaged tissue. Fraunhofer researchers have developed a cell-free substrate containing proteins to which autologous cells bind and grow only after implantation.
The son of a craftsman making Buddhist altars, he was driven to create instruments for physics and chemistry. Attending the Physics and Chemistry Research Institute he gained experience with a variety of technologies and fields of expertise. He was convinced that Japan, as a should work towards becoming a leader in science. At the dawn of the industrial revolution and scientific age in 1875 he…
Researchers from the University of Heidelberg and the German Cancer Research Center (DKFZ) have developed a new method that uses light to control processes in living cells.
How do our brains combine information from the external world (sensory stimulation) with information on our internal state such as hunger, fear or stress?
To deliver the next step forward in mechanical ventilation, Jens Viebke, CEO of the Maquet-Getinge Group, decided to take a step backwards by first talking with the people who would be using the system.
Although traditionally exporting timber and machinery, today Finland has established itself as a producer of high-tech products. This includes innovative medical technology.
Over the past decade, laboratory medicine developed rapid, accurate tests that help in diagnoses, prognoses, treatments – and the overall theragnostics; but is it economical? This November, at the Journées Internationales de Biologie (JIB) meeting in Paris, that question will shape the medical economics session Medical biology: a key factor in the healthcare effectiveness, organised by the in…
Double-digit growth in Asia-Pacific and emerging markets to offset stagnation in US and Europe.
Cardiologists believe they can restore coronary arteries thanks to a new generation of stents that help the body to strengthen collapsed vessels. Elsewhere, patients’ own stem cells are being programmed to rebuild cardiac muscle in HF patients.
Apart from tumour immunologists themselves, for a long time oncologists have underestimated the role of the immune system in cancer treatment. Nonetheless, in recent years increasing attention has been given to this aspect of cancer.
According to Molly Polen, at the AACC, great opportunities lie ahead for laboratory medicine and, to seize them, ‘meeting with colleagues and learning about new technologies is a critical first step. The 2013 AACC will provide these and other opportunities, such as informative sessions and live demonstrations of new technology.’
Next April, 28-30, an unprecedented event will make its debut on this side of the world.
French and German experts hear of a possible new computer-based system to identify new biomarkers for colon cancer.
A novel, entirely biodegradable device has been successfully implanted in a blocked artery patient needing a percutaneous coronary intervention
Artificial vascular trees, the growing of heart tissue, nerve regeneration: The World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) held in Vienna this October offered an impressive display of current developments in tissue reconstruction and regeneration, Michael Krassnitzer reports
In a paper published in ”Nature Biotechnology” on the 22nd of July of 2012 Harvard researchers explain how making a jellyfish from rat DNA can help to solve cardiac problems.
The world’s first gene cancer therapy study of an innovative oral vaccine is underway at the Surgical Clinic of Heidelberg University Hospital.
‘Nowadays, there are not that many opportunities for EU countries to expand technological progress,’ said Ambassador Dr Jan Koukal when he called for the trans-border utilisation of ‘neighbourly’ potential during his opening speech at the joint Czech-Austrian seminar.
Modern medical technology is evidently held in high esteem by the general population. In a recent survey conducted by the market research institute Emnid commissioned by the industry association SPECTARIS, about 80% of the patients surveyed said that under certain circumstances they would be willing to pay more for their health insurance in return for consistent treatment with state-of-the-art…
One of the world’s leading public health establishments, AP-HP (Assistance Publique-Hôpitaux de Paris) generated EUR 17 million in revenues thanks to its technology transfer arm, OTTLIV, in 2010. OTTLIV (Office of Technology Transfer, Licensing and Industrial Ventures), a small team of professionals, raised income from license fees, royalties and collaborative research projects.
The birth, in France, of its first baby to be conceived by artificial insemination on top of the selection of an embryo based on its blood, has sent new flames into the hot parliamentary debate over the reform of bioethics law.
Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject. Studying Drosophila…
The 'omics' revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. Biomarkers have a multitude of applications such as early disease detection, identifying potential drug targets, predicting patient response to medication and accelerating clinical trials. Along with its role in making personalised medicine…
When over 3,000 international experts gathered at the World Congress on Medical Physics and Biomedical Engineering in Munich, Germany to evaluate future trends, they heard that Asia is showing major gains in medical engineering — a field in which computer sciences are a key innovation driver – but that Europe is on the way to innovation leadership in telemedicine and e-health.
The Innovation Prize for outstanding, application-oriented ideas in life sciences has been awarded by the Working Group of BioRegions at the Biotechnica in Hanover to research groups from Heidelberg, Munich and Ulm. Professor Lisa Wiesmüller, of the Women’s Hospital, University of Ulm, received the €2,000 prize for developing a test system for the identification and early detection of breast…
Positive CB7630 (Abiraterone Acetate) Phase II Data was presented at the ASCO Annual Meeting in Chicago this May/June, Cougar Biotechnology Inc, a development stage biopharmaceutical firm with a specific focus on oncology. In mid-July, Johnson & Johnson announced its acquisition of Cougar, which is now working with Ortho Biotech Oncology Research & Development, a division of the J&J firm Centocor…
Newly designed centerpieces used in the Beckman Coulter XL-A and XL-I instruments - the only analytical ultracentrifuges on the market today - allow the systems to provide precise, repeatable measurement of pharmaceutical sample aggregation in pharmaceutical research and formulation laboratories.
The Institute for Hygiene and Biotechnology (IHB) at Hohenstein has developed the first textile that can release medically effective gasses. The textile was developed at the IHB under the auspices of a broader research project. The textile will be used in future therapeutic applications.
As processes become more complex, the need for increased laboratory safety is paramount. Protecting operators from hazardous substances, aerosol release or spillages is a critical consideration during processes, whether they are mixing substances or dispensing drugs. Of equal importance is the need to protect the substance, or product, from contamination from the operator. Mark Nicholls presents…
Among 2,552 European R&D projects (clinical phases I-III) conducted by small and mid-size biotechnology firms (under 600 employees), 64 are focused on diabetes, according to a large, detailed study carried out by Novumed Life Science Consulting.
The Universities of Exeter and Bath (UK) have revealed their plans for a new world-leading research centre to explore and exploit the properties of the thinnest material in nature. The two universities have won a £5 million Science and Innovation Award from the Engineering and Physical Sciences Research Council (EPSRC) to create the Centre of Graphene Science.
The current global financial crisis is like to hit Bio-tech and pharmaceutical companies due to a lack of funding for research and the discovery and production of many new drugs, according to Professor David Wield, Director of the Economic and Social Research Council's (ESRC) Edinburgh-based Innogen Centre, and chair of the recent international ESRC conference Genomics and Society: Reinventing…
When the first `diagnostics week´ was held 40 years ago the exhibition attracted just a handful of companies, all from the laboratory sector. At the time, no one could have known that this sedate event would eventually develop into the world's biggest medical exhibition, MEDICA.
The machine 'qViro' which is the size of a coffee grinder will make virus counting much cheaper than traditional virus counting technology. The revolutionary new invention offers the potential to quickly muster and count the number of viruses in a sample in minutes - it is a portable, desktop instrument, powered from the USB drive of a computer - current competitors are the size of washing…
London and Cambridge-based biopharmaceutical research firm Domainex Ltd has received a European patent for its Combinatorial Domain Hunting (CDH) Technology, which enables the cloning and expression of recombinant proteins, or parts of proteins (domains), from challenging molecular targets.
The programme for this year's European Health Forum Gastein (EHFG) - its 10th gathering - covers a far broader range of topics than before. During over 20 plenary sessions, forums and workshops, with about 120 lectures, key topics that embrace European and the national health politics of EU member states will be presented and discussed by experts.
More than 250,000 women under the age of forty are living with the disease in the US and 11,000 will be diagnosed in the next year. Even so, young women are underrepresented in many research studies and treatments, according to genomic expert Simon Chin.
Bayer and its affiliated firm Icon Genetics developed an own production process which provides the opportunity to make therapeutic proteins from tobacco plants. The pilot plant for biotech drugs opened on June 16 in Halle, Saxony-Anhalt.
Analytica, to be held in Munich for the 21st time, has become a leading international trade fair for instrumental analysis, laboratory technology and biotechnology, showcasing the entire range of equipment, solutions and services for laboratories in industry and research. About 400 exhibitors will fill five halls in the New Munich Trade Fair Centre.
Every developing tissue is supplied by blood vessels with oxygen and nutrients. Tumours grow far more quickly than normal tissues, so have a greater need of nutrients, which is why tumour cells begin to produce growth factors that stimulate the formation of blood vessels.
Where are the most high-tech start-ups? That`s an easy one: Silicon Valley. But who comes in a close second? Surprisingly: Israel. Further: Israel ranks Number 1 in terms of availability of scientists and engineers and Number 2 in quality of higher education. The result of this impressive track record is a wide range of successful enterprises and products, particularly related to the life…
21st. Analytica 2008 held in april 2008 in Munich, Germany.
The market for Electronic Lab Notebooks (ELN) is booming. Experts assume that technological developments and the growing demand to archive and store lab-data and therefore improve the productivity are the main reasons for this positive trend.
The European Parliament voted for an EU Regulation on advanced therapies like gene therapy, cell therapy and tissue engineering. The decision, if adopted by the council, could open the door for innovative therapies which have a huge potential for curing diseases such as Parkionson´s, Alzheimer or cancer.
According to an as yet undefined ruling of the European Court of Justice, EU patients whose names have been on long waiting lists for surgery in their homeland now have a right to be treated in another EU country, and this is to be reimbursed by their national health insurers.
The Saint Ann Hospital, in Brno, is about to commence a joint project with the renowned Mayo Clinic, based in Rochester, Minnesota, USA.
Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…
The 2006 Eppendorf and Science prize, the annual international research prize of US$25,000 has been awarded to Doris Tsao PhD, of the USA.
The IMS 2007 Pharmaceutical Market Forecast predicts a 5-6% international growth in the global pharmaceuticals market.
The objective of the CNIC is to lead cardiovascular research in Spain and establish itself as a leading international centre.
Dr Hanns-Joachim Weinmann, Diagnostics and Radiopharmaceuticals, Magnetic Resonance Imaging & X-Ray Research, Schering AG, examines what is feasible and what still lies only at a tantalising distance.
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Bologna, Italy - With 670 exhibitors - 595 domestic and 78 international companies from 18 countries as well as 344 represented companies from 36 countries - and close to 28,000 visitors, the medical event Exposanita was, once again, a huge success.
The fundamental role of inflammation in almost all disease processes has been increasingly recognised over several years.
When heart valves need replacing mechanical or biological heart valves are usually used. Both have disadvantages: Mechanical prostheses promote the development of blood clots so that patients need anticoagulant treatment for their lifetime.
Czech Republic - The US firm Baxter International Inc. is to establish a production facility to produce a quite unique vaccine in CR. First discussed in December 2005, the plan appears to have made a significant step forward. Baxter specialises in medical devices, pharmaceuticals, and biotechnology, and globally employs around 48,000 people in 64 manufacturing facilities, which include those in…
The Med-e-Tel eHealth conference and trade show from 5 to 7 April 2006, Venue, Luxembourg, will again attrackt healthcare professionals.
Red green and white biotechnology
Tissue engineering caused a stir at the 34th Annual Meeting of the Germany Society for Thoracic and Cardiovascular Surgery.
Medication regimes based on cocktails of antiretroviral drugs can reduce the AIDS virus to almost undetectable levels.
Live 'drug transporters' - bacteria that deliver medication to targeted body areas; a coating for tooth implants that promotes bone growth; biochips to test the potential effects of a medication on particular patients, and miniature genetic point-of-care testing laboratories (POCT) for use during medical emergencies, were among exciting developments demonstrated by 270 exhibitors from 14…
